A herpes virus peptide binds and sequesters proteins important for MYC activation in lymphoma cells, presenting a new viral strategy for treating undruggable MYC-dependent cancers.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.